US 7329671
2,4-pyrimidinediamine compounds and their uses
granted A61KA61K31/505A61K31/506
Quick answer
US patent 7329671 (2,4-pyrimidinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/505, A61K31/506, A61K31/519, A61K31/5377